Identification of reprogrammed myeloid cell transcriptomes in NSCLC

Anna Durrans, Dingcheng Gao, Ravi Gupta, Kari R. Fischer, Hyejin Choi, Tina El Rayes, Seongho Ryu, Abu Nasar, Cathy F. Spinelli, Weston Andrews, Olivier Elemento, Daniel Nolan, Brendon Stiles, Shahin Rafii, Navneet Narula, Ramana Davuluri, Nasser K. Altorki, Vivek Mittal

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Lung cancer is the leading cause of cancer related mortality worldwide, with non-small cell lung cancer (NSCLC) as the most prevalent form. Despite advances in treatment options including minimally invasive surgery, CT-guided radiation, novel chemotherapeutic regimens, and targeted therapeutics, prognosis remains dismal. Therefore, further molecular analysis of NSCLC is necessary to identify novel molecular targets that impact prognosis and the design of new-targeted therapies. In recent years, tumor "activated/reprogrammed" stromal cells that promote carcinogenesis have emerged as potential therapeutic targets. However, the contribution of stromal cells to NSCLC is poorly understood. Here, we show increased numbers of bone marrow (BM)-derived hematopoietic cells in the tumor parenchyma of NSCLC patients compared with matched adjacent non-neoplastic lung tissue. By sorting specific cellular fractions from lung cancer patients, we compared the transcriptomes of intratumoral myeloid compartments within the tumor bed with their counterparts within adjacent non-neoplastic tissue from NSCLC patients. The RNA sequencing of specific myeloid compartments (immature monocytic myeloid cells and polymorphonuclear neutrophils) identified differentially regulated genes and mRNA isoforms, which were inconspicuous in whole tumor analysis. Genes encoding secreted factors, including osteopontin (OPN), chemokine (C-C motif) ligand 7 (CCL7) and thrombospondin 1 (TSP1) were identified, which enhanced tumorigenic properties of lung cancer cells indicative of their potential as targets for therapy. This study demonstrates that analysis of homogeneous stromal populations isolated directly from fresh clinical specimens can detect important stromal genes of therapeutic value.

Original languageEnglish (US)
Article numbere0129123
JournalPLoS ONE
Issue number6
StatePublished - Jun 5 2015

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Identification of reprogrammed myeloid cell transcriptomes in NSCLC'. Together they form a unique fingerprint.

Cite this